Related Experiment Video
Updated: Apr 6, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Endomembrane PtdIns(3,4,5)P3 activates the PI3K-Akt pathway
Nirmal Jethwa1, Gary H C Chung1, Marta G Lete2
1Cell Biophysics Laboratory, Cancer Research UK, London WC2A 3LY, UK.
The protein kinase B (PKB/Akt) pathway, crucial for cancer, can be activated within cellular compartments like the nuclear envelope and endosomes. This localized activation, dependent on phosphatidylinositol (3,4,5)-trisphosphate, suggests new therapeutic targets for cancer.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Signal Transduction
Background:
- Protein kinase B (PKB/Akt) activation is integral to tumor growth, proliferation, and survival.
- Akt activation typically occurs at the plasma membrane, triggered by growth factors and phosphatidylinositol 3-kinase (PI3K) signaling.
- The localization and function of internal phosphatidylinositol (3,4,5)-trisphosphate [PtdIns(3,4,5)P3] pools remain areas of investigation.
Purpose of the Study:
- To investigate the localization of PtdIns(3,4,5)P3 within cellular compartments.
- To determine if Akt can be activated in these internal compartments.
- To explore the implications of localized Akt activation for cancer therapy.
Main Methods:
- Utilized transfected and recombinant protein probes to detect PtdIns(3,4,5)P3.
- Employed an inducible dimerization system to recruit Akt to specific cellular compartments.
- Assessed Akt activation and its potential to phosphorylate downstream substrates in a compartment-specific manner.
Main Results:
- Demonstrated enrichment of PtdIns(3,4,5)P3 in the nuclear envelope and early endosomes.
- Showed that Akt can be locally activated in these compartments in a PtdIns(3,4,5)P3-dependent manner.
- Indicated that compartmentally localized Akt can phosphorylate downstream substrates.
Conclusions:
- Subcellular localization of PtdIns(3,4,5)P3 and Akt activation offers a novel mechanism for regulating PI3K pathway signaling and substrate specificity.
- Aberrant phosphoinositide metabolism contributes to cancer, highlighting subcellular compartments as potential therapeutic targets.
- Targeting these localized signaling events may provide new avenues for cancer treatment.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
IP3/DAG Signaling Pathway
The JAK-STAT Signaling Pathway
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

